Verastem Historical Income Statement

VSTM Stock  USD 4.00  0.07  1.78%   
Historical analysis of Verastem income statement accounts such as Depreciation And Amortization of 58.9 K, Interest Expense of 5 M, Selling General Administrative of 35.8 M or Other Operating Expenses of 79.9 M can show how well Verastem performed in making a profits. Evaluating Verastem income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Verastem's future profits or losses.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Verastem latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Verastem is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.

About Verastem Income Statement Analysis

Verastem Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Verastem shareholders. The income statement also shows Verastem investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Verastem Income Statement Chart

At this time, Verastem's Interest Expense is very stable compared to the past year. As of the 24th of November 2024, Selling General Administrative is likely to grow to about 35.8 M, while Other Operating Expenses is likely to drop about 79.9 M.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Verastem. It is also known as Verastem overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Total Revenue

Total revenue comprises all receipts Verastem generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.
Most accounts from Verastem's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Verastem current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.At this time, Verastem's Interest Expense is very stable compared to the past year. As of the 24th of November 2024, Selling General Administrative is likely to grow to about 35.8 M, while Other Operating Expenses is likely to drop about 79.9 M.

Verastem income statement Correlations

0.230.370.10.060.140.070.22-0.03-0.44-0.01-0.02-0.190.18-0.49-0.290.3
0.230.93-0.78-0.80.51-0.80.94-0.8-0.13-0.81-0.830.510.19-0.750.520.76
0.370.93-0.82-0.840.74-0.830.98-0.85-0.19-0.83-0.840.380.01-0.730.530.57
0.1-0.78-0.821.0-0.811.0-0.90.96-0.030.940.92-0.390.220.4-0.78-0.31
0.06-0.8-0.841.0-0.811.0-0.920.970.00.950.93-0.390.160.44-0.73-0.35
0.140.510.74-0.81-0.81-0.810.78-0.780.01-0.73-0.690.2-0.32-0.270.54-0.02
0.07-0.8-0.831.01.0-0.81-0.910.97-0.010.950.93-0.390.160.43-0.74-0.34
0.220.940.98-0.9-0.920.78-0.91-0.9-0.09-0.89-0.890.460.0-0.660.60.55
-0.03-0.8-0.850.960.97-0.780.97-0.90.240.990.98-0.190.160.58-0.7-0.37
-0.44-0.13-0.19-0.030.00.01-0.01-0.090.240.30.30.72-0.130.660.18-0.22
-0.01-0.81-0.830.940.95-0.730.95-0.890.990.30.99-0.170.10.62-0.67-0.41
-0.02-0.83-0.840.920.93-0.690.93-0.890.980.30.99-0.20.040.65-0.65-0.47
-0.190.510.38-0.39-0.390.2-0.390.46-0.190.72-0.17-0.20.27-0.030.260.39
0.180.190.010.220.16-0.320.160.00.16-0.130.10.040.27-0.38-0.660.6
-0.49-0.75-0.730.40.44-0.270.43-0.660.580.660.620.65-0.03-0.38-0.08-0.66
-0.290.520.53-0.78-0.730.54-0.740.6-0.70.18-0.67-0.650.26-0.66-0.080.06
0.30.760.57-0.31-0.35-0.02-0.340.55-0.37-0.22-0.41-0.470.390.6-0.660.06
Click cells to compare fundamentals

Verastem Account Relationship Matchups

Verastem income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization171.9K1.3M206K118K62K58.9K
Interest Expense20.6M15.8M10.0M2.1M4.1M5.0M
Selling General Administrative101.2M62.8M24.1M25.0M28.2M35.8M
Other Operating Expenses149.8M137.9M63.5M75.5M92.1M79.9M
Operating Income(132.3M)(49.4M)(61.4M)(72.9M)(92.1M)(96.7M)
Ebit(126.6M)(51.7M)(61.2M)(71.7M)(83.2M)(87.4M)
Research Development45.8M41.4M39.3M50.6M61.4M40.8M
Ebitda(126.4M)(50.4M)(61.0M)(71.6M)(83.2M)(87.3M)
Total Operating Expenses147.0M104.1M63.5M75.5M92.1M76.8M
Income Before Tax(149.2M)(67.5M)(71.2M)(73.8M)(87.4M)(91.7M)
Total Other Income Expense Net(16.9M)(18.2M)(9.8M)(875K)4.7M5.0M
Net Income(169.2M)(67.7M)(81.1M)(73.8M)(87.4M)(91.7M)
Gross Profit14.6M54.8M1.8M2.5M(62K)(58.9K)
Net Income From Continuing Ops(149.2M)(67.7M)(71.2M)(73.8M)(76.8M)(80.6M)
Cost Of Revenue2.8M33.7M206K118K62K58.9K
Non Operating Income Net Other3.7M(2.4M)181K1.3M1.5M1.4M
Net Income Applicable To Common Shares(149.2M)(67.7M)(71.2M)(73.8M)(66.4M)(69.8M)
Income Tax Expense20.0M194K9.9M36K(87.4M)(83.0M)
Net Interest Income(16.2M)(15.3M)(9.8M)(922K)1.4M1.4M
Interest Income4.4M515K181K1.2M5.1M5.4M
Reconciled Depreciation2.2M1.3M72K(36K)(84K)(79.8K)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Verastem is a strong investment it is important to analyze Verastem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verastem's future performance. For an informed investment choice regarding Verastem Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.14)
Revenue Per Share
0.331
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.47)
Return On Equity
(1.37)
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.